The press conference on the most influential list of China's pharmaceutical industry hosted by the chamber of Commerce for medical and pharmaceutical industry of all China Federation of industry and Commerce has been held for five consecutive times, becoming the annual brand event of China's pharmaceutical industry. Shandong Yingsheng Biotechnology Co., Ltd. participated in the list selection of the most influential series in the pharmaceutical industry in 2018, and won the title of "China medical device technology innovation enterprise in 2018"

Shandong Yingsheng Biotechnology Co., Ltd. has been a leader in the development and service of clinical mass spectrometry and gene detection technology in China since its establishment for more than ten years. Focusing on metabonomics and genemics, the company has built a leading gene detection platform and mass spectrometry detection platform in China. In terms of mass spectrometry detection platform, Yingsheng biology has successfully developed domestic leading full spectrum vitamin detection reagents, 48 diagnostic reagents for genetic and metabolic diseases, drug concentration and metabolism monitoring and other products and related report analysis software by using independent innovation technology. Meanwhile, it has cooperated with thermo through international cooperation Fisher, Hamilton, biotechnology, labsystems and other international companies have established close international partnerships, created a leading one-stop solution for clinical mass spectrometry automation, process, intelligence and standardization in China, become the most reliable technical means innovator for safeguarding the health of women and children in China, and actively promote the rapid development of precision medicine industry in China